Trials / Withdrawn
WithdrawnNCT02278445
Evaluation of Pulmonary Doppler Signals in Patients With Systemic Sclerosis(SSc)
Evaluation of Lung Doppler Signals (LDS) in Detecting Pulmonary Arterial Hypertension in Patients With Systemic Sclerosis (SSc)
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Echosense Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Doppler signals can be recorded from the lung parenchyma by means of a pulsed Doppler ultrasound system incorporating a special signal processing package- the Transthoracic Parametric Doppler (TPD) (Echosense Ltd., Haifa, Israel). Systemic sclerosis patients often develop pulmonary vascular disease leading to pulmonary hypertension. The TPD system may provide important insight into pulmonary blood vessels characteristics by the LDS (Lung Doppler Signals) signals that are related to pulmonary hypertension. The TPD performance in detecting PAH in SSc patients will be assessed in the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Doppler ultrasound | Recording Doppler ultrasound noninvasively from the right chest wall |
| DEVICE | Transthoracic Parametric Doppler (TPD) (Echosense Ltd., Haifa, Israel) |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2015-11-01
- Completion
- 2015-12-01
- First posted
- 2014-10-30
- Last updated
- 2015-12-02
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT02278445. Inclusion in this directory is not an endorsement.